Guided Therapeutics (OTC:GTHP) is getting its requested date with the FDA’s medical device regulators, during which the company hopes to revive its rejected bid to win approval for the LuViva cervical scanner.
Oncology
Delcath Systems tanks following reverse stock split
Breast cancer: Mammograms don’t reduce deaths, researchers say
Breast cancer experts are calling for a fresh look at routine mammography, warning that screening may not save lives and may instead lead to risky overdiagnoses.
Varian closes stealthy acquisition of Velocity cancer-management software
California device maker Varian Medical (NYSE:VAR) remained tight-lipped about its bid for software maker Velocity Medical Solutions as it announced the acquisition’s close today.
Cancer: RefleXion Medical raises $11.6M to ‘make radiotherapy personal’
California-based medtech group RefleXion Medical touted an $11.6 million Series A fundraising round, hoping to use the new funds to expand research & development efforts for its guided radiation therapy technology.
Veran nears $5M fundraising goal for airway imaging
Missouri-based Veran Medical Technologies is on the verge of closing a $5 million funding round in support of its electromagnetic airway mapping system, regulatory filings show.
Varian to acquire cancer software maker Velocity Medical
Varian Medical (NYSE:VAR) said it inked a deal to acquire Velocity Medical Solutions’ cancer clinic software.
OnTarget Labs lands $15M for tumor fluorescing tech
OnTarget Laboratories said it landed a $15 million investment from a pair of backers for its tumor-lighting technology developed at Purdue University by the founder of Endocyte (NSDQ:ECYT).
Lumicell adds another $600,000 in funding
Imaging systems maker Lumicell Diagnostics amended a previously closed $1 million funding round after landing another $560,000 in financing from 2 new investors, regulatory filings show.
Partnership aims to turn the tables on childhood cancer in the Middle East
By Lisa Fratt
Geography can be cruel. An 8-year-old diagnosed with leukemia in Europe or North America can expect a challenging but curable course. Her care, provided by a team of pediatric specialists, includes state-of-the-art imaging, thorough infection prevention and, often, multiple options for treatment.
A 6-minute breathalyzer for breast cancer | MassDevice.com On Call
MASSDEVICE ON CALL — Diagnostics maker Menssana Research is making promising progress with a breath-test that the company says can identify at-risk breast cancer cases in just 6 minutes.
In a study of nearly 250 women at 3 centers in New Jersey, Washington and the Netherlands the test was able to accurately identify women with early stage breast cancer or with abnormal mammogram, Menssana said.